Early Insights from a Digitally Enhanced Diabetes Self-Management Education and Support Program: A Single-Arm Non-Randomized Trial
ABSTRACT
Background:
Translation of diabetes self-management education and support (DSMES) into a digital format can improve access, but few digital programs have demonstrated outcomes using rigorous evaluation metrics.
Objective:
To evaluate the impact of a digital DSMES program on glycemic control for type 2 diabetes.
Methods:
A single-arm, non-randomized trial was conducted to evaluate a digital DSMES program that includes remote monitoring and lifestyle change, in addition to comprehensive diabetes education, staffed by a diabetes specialist. A sample of 195 participants were recruited using an online research platform (Achievement Studies, Evidation Health Inc). The primary outcome was change in laboratory-tested hemoglobin A1c (HbA1c) from baseline to 4 months, and secondary outcomes included change in lipids, diabetes distress, and medication adherence.
Results:
At baseline, participants had a mean HbA1c of 8.9% (SD=1.9) and mean body mass index (BMI) of 37.5 kg/m2 (SD=8.3). The average age was 45.1 years (SD=8.9), 70% were women, and 67% were White. At 4-month follow-up, the HbA1c decreased by 0.8% (P<.001, 95% CI [-1.1, -0.5]) for the total population and decreased by 1.4% (P<.001, 95% CI [-1.8, -0.9]) for those with worse glucose control at baseline (HbA1c=9.0%+). Diabetes distress and medication adherence were also significantly improved between baseline and follow-up.
Conclusions:
This study provides early evidence that a digitally enhanced DSMES program improves glycemic control and disease self-management outcomes.
Citation

Per the author's request the PDF is not available.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.